TLON..$.935 Will be revisiting this one as well this weekend and posting some good information (article from Nov 2011) I came across on "accelerated approvals". Really strong in favor of what TLON is doing during this FDA process. Whether they enroll a patient on the Phase III conf study is important. I think it adds "icing" to the cake. Even without that, the study has been initiated. The FDA has indicated they want to see patient enrollment at the time of approval (5/13) so that would be the most important thing for the company.